Metabotropic Glutamate Receptor Type 4 Is Involved in Autoinhibitory Cascade for Glucagon Secretion by α-Cells of Islet of Langerhans
- Shunsuke Uehara,
- Akiko Muroyama,
- Noriko Echigo,
- Riyo Morimoto,
- Masato Otsuka,
- Shouki Yatsushiro and
- Yoshinori Moriyama
- From the Department of Biochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Okayama, Japan
- Address correspondence and reprint requests to Dr. Y. Moriyama, Department of Biochemistry, Faculty of Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan. E-mail: moriyama{at}pheasant.pharm.okayama-u.ac.jp
Abstract
In islets of Langerhans, l-glutamate is stored in glucagon-containing secretory granules of α-cells and cosecreted with glucagon under low-glucose conditions. The l-glutamate triggers secretion of γ-aminobutyric acid (GABA) from β-cells, which in turn inhibits glucagon secretion from α-cells through the GABAA receptor. In the present study, we tested the working hypothesis that l-glutamate functions as an autocrine/paracrine modulator and inhibits glucagon secretion through a glutamate receptor(s) on α-cells. The addition of l-glutamate at 1 mmol/l; (R,S)-phosphonophenylglycine (PPG) and (S)-3,4-dicarboxyphenylglycine (DCPG), specific agonists for class III metabotropic glutamate receptor (mGluR), at 100 μmol/l; and (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) at 50 μmol/l inhibited the low-glucose–evoked glucagon secretion by 87, 81, 73, and 87%, respectively. This inhibition was dose dependent and was blocked by (R,S)-cyclopropyl-4-phosphonophenylglycine (CPPG), a specific antagonist of class III mGluR. Agonists of other glutamate receptors, including kainate and quisqualate, had little effectiveness. RT-PCR and immunological analyses indicated that mGluR4, a class III mGluR, was expressed and localized with α- and F cells, whereas no evidence for expression of other mGluRs, including mGluR8, was obtained. l-Glutamate, PPG, and ACPT-I decreased the cAMP content in isolated islets, which was blocked by CPPG. Dibutylyl-cAMP, a nonhydrolyzable cAMP analog, caused the recovery of secretion of glucagon. Pertussis toxin, which uncouples adenylate cyclase and inhibitory G-protein, caused the recovery of both the cAMP content and secretion of glucagon. These results indicate that α- and F cells express functional mGluR4, and its stimulation inhibits secretion of glucagon through an inhibitory cAMP cascade. Thus, l-glutamate may directly interact with α-cells and inhibit glucagon secretion.
- ACPT-I, (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid
- AMPA, (RS)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
- CPPG, (R,S)-cyclopropyl-4-phosphonophenylglycine
- DBcAMP, dibutyryl cAMP
- DCPG, (S)-3,4-dicarboxyphenylglycine
- DMEM, Dulbecco’s modified Eagle’s medium
- dNTP, deoxynucleotide triphosphate
- GABA, γ-aminobutyric acid
- Gi, inhibitory G-protein
- GST, glutathione S-transferase
- l-CCG-I, (2S,3S,4S)-2(carboxycyclopropyl)glycine
- LY341495, (2S,1′S,2′S)-2-(2-carboxycyclopropyl)-2-(9H-xanthen-9-yl)glycine
- mGluR, metabotropic glutamate receptor
- PPG, (R,S)-phosphonophenylglycine
- PTX, pertussis toxin
- (S)-3,5-DHPG, (S)-3,5-dihydroxyphenylglycine
- trans-ACPD, (±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid
Footnotes
-
S.U. and A.M. contributed equally to the present study.
-
- Accepted January 5, 2004.
- Received September 22, 2003.
- DIABETES














